Meet the expert: Innovative Closed Process CAR-T Cell Therapy Platform: A Streamlined Approach for Manufacturing with Great Predictability

Tuesday, January 26, 2021 - 19:30 to Wednesday, January 27, 2021 - 19:50
Advanced Therapies Connect 2021 - Phacilitate's 2nd Virtual Experience - WATCH


Developing innovative advanced therapies is one of our greatest opportunities to dramatically improve patients’ lives. WuXi Advanced Technologies recently announced the expansion of its service capabilities by offering a fully integrated CAR-T cell therapy platform to help accelerate the timeline for cell and gene therapy development, manufacturing, and release while providing greater predictability.
This session will showcase a method for accelerating timelines and progress to market for CAR-T production that includes: in-stock raw materials with established batch records; regulatory and technical expertise; process and analytical development; full in-process and release testing; robust quality control and quality assurance oversight; and facilities that offer the capacity and flexibility to meet client timeline needs. 

Related Information


Poonam Sharma
Senior Scientist Process Development and Commercialization - Wuxi Advanced Therapies


Key Takeaways:
  • How a closed-process CAR-T cell therapy platform streamlines manufacturing
  • How to accelerate timelines and progress to market for CAR-T production
  • How to mitigate risk with greater predictability through a fully integrated platform
< Back